0001437749-13-008385.txt : 20130702
0001437749-13-008385.hdr.sgml : 20130702
20130702174722
ACCESSION NUMBER: 0001437749-13-008385
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130630
FILED AS OF DATE: 20130702
DATE AS OF CHANGE: 20130702
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Furiex Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001484478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271197863
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3900 PARAMOUNT PARKWAY
STREET 2: SUITE 150
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-456-7800
MAIL ADDRESS:
STREET 1: 3900 PARAMOUNT PARKWAY
STREET 2: SUITE 150
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: PPD Therapeutics, Inc.
DATE OF NAME CHANGE: 20100218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ESHELMAN FREDRIC N
CENTRAL INDEX KEY: 0001033409
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34641
FILM NUMBER: 13950111
MAIL ADDRESS:
STREET 1: PPD INC
STREET 2: 929 NORTH FRONT STREET
CITY: WILMINGTON
STATE: NC
ZIP: 28401
4
1
rdgdoc.xml
PRIMARY DOCUMENT
X0306
4
2013-06-30
0001484478
Furiex Pharmaceuticals, Inc.
FURX
0001033409
ESHELMAN FREDRIC N
C/O FURIEX PHARMACEUTICALS, INC.,
3900 PARAMOUNT PARKWAY, SUITE 150
MORRISVILLE
NC
27560
1
1
Common Stock
2013-06-30
4
A
0
7161
0
A
2673522
D
Common Stock
132689
I
LLC
Common Stock
41666
I
GRAT
Common Stock
140
I
Spouse
Stock Options (to buy)
9.11
2020-06-17
Common Stock
65876
65876
I
LLC
Stock Options (to buy)
13.16
2021-10-03
Common Stock
98813
98813
I
LLC
The restricted stock was awarded on 6/30/2013 and vests in its entirety on the earlier of 5/24/2014 or immediately prior to the 2014 Annual Stockholder meeting, provided that the Grantee is still at that time serving on the Company's Board of Directors.
The options were awarded on 6/17/2010 and vest over three years, with one-third of the options vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's consulting relationship continues.
The options were awarded on 10/3/2011 and vest over three years, with one-third of the options vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's consulting relationship continues.
/s/ Donald R. Reynolds, by Power of Attorney
2013-07-02